Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04517877 · ClinicalTrials.gov registry record · Phase 2
Caring Light Project for Family Caregivers
A Phase 2 study of Alzheimer Disease, sponsored by Photozig.
- Completed
- Registry status
- Phase 2
- Development phase
- 164
- Enrollment target
- 1
- Study location
NCT04517877 is a Phase 2 study of Alzheimer Disease that has completed, run by Photozig. The registered enrollment target is 164 participants, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04517877, a Phase 2 study of Alzheimer Disease, has completed, sponsored by Photozig.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 164 participants
- Enrollment target
- 1
- Study location
Study Summary
Caring Light is designed to help caregivers of someone with Alzheimer's Disease and related dementia to cope with the difficulties related to caregiving, reduce stress, and improve quality of life.
Conditions Studied
Interventions
- BEHAVIORAL Caring Response App
- BEHAVIORAL Traditional Educational/Resources Program
Study Locations (1)
California
- Photozig, Inc. - Mountain View
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164 participants |
| Start Date | 2020-07-15 |
| Est. Completion | 2021-05-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04517877
The ClinicalTrials.gov registry entry for NCT04517877 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 164 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (94% lower). The listed sponsor is Photozig, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Alzheimer Disease appearing as the primary indexed condition, and to 2 interventions - of which Caring Response App is the first listed.
NCT04517877 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04517877 about?
NCT04517877 is a clinical study titled "Caring Light Project for Family Caregivers". Caring Light is designed to help caregivers of someone with Alzheimer's Disease and related dementia to cope with the difficulties related to caregiving, reduce stress, and improve quality of life.
What is the current status of trial NCT04517877?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 164 participants. The study started on 2020-07-15. Estimated completion is 2021-05-30.
What conditions does trial NCT04517877 study?
This clinical trial studies the following conditions: Alzheimer Disease.
What interventions are being tested in trial NCT04517877?
The interventions under investigation include: Caring Response App (BEHAVIORAL), Traditional Educational/Resources Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT04517877?
This trial is sponsored by Photozig, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04517877 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Systemic and Central Inflammation in AD
RECRUITING · Phase 2
-
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
RECRUITING · Phase 2
-
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
RECRUITING · Phase 2
-
Sleep Trial to Prevent Alzheimer's Disease
RECRUITING · Phase 2
-
A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)
RECRUITING · Phase 2
-
Human Mesenchymal Stem Cells (hMSC) in Behavioral Problems Due to Alzheimer's Disease.
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.